Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
5,169,697
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
10,510,900
-
Shares change
-
+9,129,365
-
Total reported value, excl. options
-
$104,167,000
-
Value change
-
+$90,475,000
-
Number of buys
-
33
-
Price
-
$9.91
Institutional Holders of CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) as of Q4 2021
As of 31 Dec 2021 CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) had 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 10,510,900 shares of stock of the company.
Largest 10 holders included Beryl Capital Management LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, CANTOR FITZGERALD, L. P., CITADEL ADVISORS LLC, Saba Capital Management, L.P., MARSHALL WACE, LLP, Polar Asset Management Partners Inc., D. E. Shaw & Co., Inc., Weiss Asset Management LP, and Atalaya Capital Management LP.
This table shows 36 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.